Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zahravi Pharmaceutical is a leading Iranian pharmaceutical company specializing in the development and manufacture of high-tech medicinal products, with a particular focus on soft gel capsules and immunosuppressive drugs. Established in 1986 and headquartered in Tabriz, the company is a key supplier of critical medications for organ transplant patients, including brands like Cograft and Iminoral. Zahravi operates as a subsidiary of the Tamin Pharmaceutical Investment Company (TPICO) and is listed on the Tehran Stock Exchange. Its manufacturing facilities are GMP-certified and produce a wide range of dosage forms, including tablets, capsules, and ampoules, serving both domestic and international markets. The company has established strategic partnerships with international firms like Roche for the local production of specialized therapies such as CellCept and Roaccutane.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zahravi Pharmaceutical.